[Form 4] Evolus, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Stewart Brady, a director of Evolus, Inc. (EOLS), purchased 30,000 shares of the issuer's common stock on 08/15/2025 at a weighted average price of $6.8162 per share, increasing his beneficial ownership to 88,629 shares. The Form 4 reports the shares were bought in multiple trades at prices ranging from $6.7699 to $6.82, and the filing was signed by Jeffrey J. Plumer as attorney-in-fact on 08/18/2025. The transaction is reported as a purchase and the ownership is listed as direct.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director purchased 30,000 shares at a weighted average of $6.8162, raising direct holdings to 88,629 shares.
The purchase increases the director's direct stake and signals a meaningful personal investment at recent market prices. The reported weighted average price and the disclosed trade price range provide transparency on execution costs. Without information on total outstanding shares or prior ownership percentage, the absolute impact on shareholder alignment and dilution cannot be determined from this filing alone.
TL;DR: Form 4 shows a clear, properly executed insider purchase reported by attorney-in-fact.
The filing presents required disclosures: transaction date, quantity, weighted average price, and resulting beneficial ownership. The signature by an attorney-in-fact is noted and the explanatory footnote supplies the trade price range. The document contains the necessary items for Section 16 transparency; it does not, however, include any contractual plan designation or other governance actions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 30,000 | $6.8162 | $204K |
Footnotes (1)
- F1. The shares were purchased in multiple trades at prices ranging from $6.7699 to $6.82. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
AI-generated analysis. How Rhea-AI works. Not financial advice.